SNN

SNN

USD

Smith & Nephew SNATS Inc. Common Stock

$37.020+0.540 (1.480%)

Preço em tempo real

Healthcare
Dispositivos médicos
Reino Unido

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$36.480

Máximo

$37.080

Mínimo

$36.460

Volume

1.61M

Fundamentos da empresa

Capitalização de mercado

15.8B

Setor

Dispositivos médicos

País

United Kingdom

Estatísticas de negociação

Volume médio

0.67M

Bolsa de valores

NYQ

Moeda

USD

Faixa de 52 semanas

Mínimo $23.69Atual $37.020Máximo $38.79

Notícias relacionadas

GlobeNewswire

Smith+Nephew comparative study1 shows PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT

Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces findings from a newly published, first-of-its-kind comparative study of single-use negative pressure wound therapy (sNPWT) devices

Ver mais
Smith+Nephew comparative study1 shows  PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT
GlobeNewswire

UFC® and Smith+Nephew announce multi-year extension of partnership

Smith+Nephew to continue as UFC's Preferred Sports Medicine Technology Partner Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, and UFC the world's premier mixed martial arts organization, have

Ver mais
UFC® and Smith+Nephew announce multi-year extension of partnership
Analyst Upgrades

Bernstein Downgrades Smith & Nephew to Market Perform, Announces $37.5 Price Target

Bernstein analyst Lisa Clive downgrades Smith & Nephew from Outperform to Market Perform and announces $37.5 price target.

Ver mais
Bernstein Downgrades Smith & Nephew to Market Perform, Announces $37.5 Price Target
GlobeNewswire

Smith+Nephew announces new category I CPT® code for its CARTIHEAL™ AGILI-C™ Cartilage Repair Implant

Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical technology company, today announces that the American Medical Association (AMA) CPT Editorial Panel has established a Category I Current Procedural Terminology (CPT)

Ver mais
Smith+Nephew announces new category I CPT® code for its CARTIHEAL™ AGILI-C™ Cartilage Repair Implant

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.